In this study, we confirmed the AMPK/Nrf2/HO-1 signaling mediated anti-inflammatory effects of DHQ in endotoxemia and provided a basis for clinical use of anti-oxidants in inflammatory diseases. The gene discussed is HMOX1; the disease is serum lipopolysaccharide activity.